Bioabsorbable coronary stents - are these the next big thing in coronary angioplasty?

Recent Patents on Cardiovascular Drug Discovery

Volumn 5, Issue 2, 2010, Pages 86-90

  Balla, Sudarshan ^a   Aggarwal, Kul ^a,b   Nistala, Ravi ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

ABSORB; AMS; Bioabsorbable; BVS; Drug eluting stents; Poly L lactic acid; PROGRESS; Restenosis; REVA stent Igaki Tamai stent; Salicylic acid stent; Tyrosine stent; Vasoreactivity

Indexed keywords

MAGNESIUM; POLYLACTIC ACID; SALICYLIC ACID; TYROSINE; METAL; POLYMER;

ARTICLE; BIODEGRADABLE IMPLANT; BLOOD VESSEL REACTIVITY; CORONARY STENT; DRUG ELUTING STENT; HUMAN; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESTENOSIS; STENT THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; CLASSIFICATION; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; MORTALITY; PATENT; STENT; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; METALS; PATENTS AS TOPIC; POLYMERS; STENTS; TREATMENT OUTCOME; ANGIOPLASTY, BALLOON, CORONARY;

EID: 77953732519     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489010791515287     Document Type: Article

References (20)

1. Danielpour, M. Bio-absorbable stent. US20070038292 (2007).
2. Mack, B.C., Mark, D.E., Kenneth, W.W. Layered drug delivery polymer monofilament fibers. US20090155326 (2009).
3. Siren, M. Coated stent. US20090175924 (2009).
4. Kern MJ. Persistent endothelial dysfunction after drug-eluting stents: Another continuing cost of reducing restenosis. JACC Cardiovasc Interv 2008; 1(1): 72-3.
5. Kim JW, Suh SY, Choi CU, Na JO, Kim EJ, Rha SW, et al. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent. JACC Cardiovasc Interv 2008; 1(1): 65-71.
6. Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: A prospective, non-randomised multicentre trial. Lancet 2007; 369(9576): 1869-75.
7. Ghimire G, Spiro J, Kharbanda R, Roughton M, Barlis P, Mason M, et al. Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. EuroIntervention 2009; 4(4): 481-4.
8. Waksman R, Erbel R, Di Mario C, Bartunek J, de Bruyne B, Eberli FR, et al. Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. JACC Cardiovasc Interv 2009; 2(4): 312-20.
9. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000; 102(4): 399-404.
10. [10] Tsuji T, Tamai H, Igaki K, Kyo E, Kosuga K, Hata T, et al. ACCIS2001 angiography & interventional cardiology. One year follow-up of biodegradable self-expanding stent implantation in humans. J Am Coll Cardiol 2001; 37(2) Suppl 1: 47A.
11. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de novo coronary artery lesions (ABSORB): A prospective open-label trial. Lancet 2008; 371(9616): 899-907.
12. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009; 373(9667): 897-910.
13. Serruys PW, Ong AT, Piek JJ, Neumann FJ, van der Giessen WJ, Wiemer M, et al. A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention 2005; 1(1): 58-65.
14. Serruys PW, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, et al. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. EuroIntervention 2006; 2(3): 286-94.
15. Schultz RK. Bioabsorbable stent program 2005 [cited 2009 24 Aug]; Available from: http://crtonline.org/flash.aspx?PAGE_ID=1323.
16. Ormiston JA, Serruys PWS. Bioabsorbable coronary stents. Circ Cardiovasc Intervent 2009; 2(3): 255-60.
17. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002; 22(11): 1769-76.
18. Whisper™ Coronary Stent System. Available at: www.bioabsorbabletx.com/whisper.html. Last accessed on Feb 6, 2010.
19. Bosiers M, Peeters P, D'Archambeau O, Hendriks J, Pilger E, Duber C, et al. AMS INSIGHT-absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol 2009; 32(3): 424-35.
20. Peeters P, Bosiers M, Verbist J, Deloose K, Heublein B. Preliminary results after application of absorbable metal stents in patients with critical limb ischemia. J Endovasc Ther 2005; 12(1): 1-5.